Macrophage-Associated Mesenchymal Stem Cells Assume an Activated, Migratory, Pro-Inflammatory Phenotype with Increased IL-6 and CXCL10 SecretionKevin Anton, John Glod|PLoS ONE|2012Cited by 138
Pediatric Brain Tumors: Current Knowledge and Therapeutic OpportunitiesJohn Glod, Mark A. Israel, Gilbert J. Rahme et al.|Journal of Pediatric Hematology/Oncology|2016Cited by 37
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell CarcinomaJohn A. Ligon, John Glod, Karel Pacák et al.|Clinical Cancer Research|2022Cited by 22
Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell CarcinomaJohn A. Ligon, John Glod, R. Taylor Sundby et al.|Unknown|2023Cited by 0
Supplementary Appendix S1 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell CarcinomaJohn A. Ligon, John Glod, R. Taylor Sundby et al.|Unknown|2023Cited by 0